| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |